Multiple Sclerosis

New England Journal of Medicine

Volumn 307, Issue 20, 1982, Pages 1246-1251

  Mcfarlin, Dale E ^a   Mcfarland, Henry F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN;

AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; EPIDEMIOLOGY; ETIOLOGY; MULTIPLE SCLEROSIS; PERIPHERAL NERVOUS SYSTEM; SHORT SURVEY; THERAPY;

ANIMAL; ANTIBODIES, VIRAL; AUTOIMMUNE DISEASES; CORTICOTROPIN; DISEASE MODELS, ANIMAL; HUMAN; INFECTION; MEASLES VIRUS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; VIRUS DISEASES;

EID: 0020287147     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198211113072005     Document Type: Review

References (70)

1. Kurtzke J.F. Epidemiologic contributions to multiple sclerosis: an overview. Neurology (NY). 1980; 30:61-79.
2. Dean G., Kurtzke J.F. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J. 1971; 3:725-729
3. Alter M., Kahana E., Loewenson R. Migration and risk of multiple sclerosis. Neurology (Minneap). 1978; 28:1089-1093
4. Kurtzke J.F., Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol. 1979; 5:6-21.
5. Kurtzke J.F., Gudmundsson K.R., Bergmann S. Multiple sclerosis in Iceland: a post war epidemic. Neurology (NY). 1980; 30:437. abstract.
6. Marie P. Sclérose en plaques et maladies infectieuses. Prog Méd Paris. 1884; 12:287-289
7. Johnson R.T. The possible viral etiology of multiple sclerosis. In: Fried-lander WJ, ed. Advances in neurology. Vol. 13. 1975: 1-46.
8. Périer O. Electron microscopic observations on human demyelinating diseases. Int Arch Allergy. 1969; 36: Suppl:452-462
9. Prineas J. Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis. Science. 1972; 178:760-763
10. Dubois-Dalcq M., Schumacher G., Sever J.L. Acute multiple sclerosis: electron microscopic evidence for and against a viral agent in the plaques. Lancet. 1973; 2:1408-1411
11. Raine C.S., Powers J.M., Suzuki K. Acute multiple sclerosis: confirmation of “paramyxovirus-like” intranuclear inclusions. Arch Neurol. 1974; 30:39-46.
12. Haase A.T., Ventura P., Gibbs C.J. Jr. Tourtellotte WW. Measles virus nucleotide sequences: detection by hybridization in situ. Science. 1981; 212:672-675
13. Fraaser N.W., Lawrence W.C., Zofia W., Gilden D.H., Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci USA. 1981; 78:6461-6465
14. Kuhn P., Steier G. Uber die Ursache der multiplen Sklerose. Med Klin. 1917; 13:1007-1009
15. Ichelson R.R. Cultivation of spirochaetes from spinal fluids of multiple sclerosis cases and negative controls. Proc Soc Exp Biol Med. 1957; 95: 57-58.
16. Chevassut K. The aetiology of disseminated sclerosis. Lancet. 1930; 1:552-560
17. Béquignon R. De l#x0027;etiologie de la sclérose en plaques. C R Acad Sci [D] (Paris). 1956; 242:1380-1382
18. Bychkova E.N. Viruses isolated from patients with encephalomyelitis and multiple sclerosis. Communication 1: Pathogenic and antigenic properties of the strains. Vopr Virus. 1964; 9:173-176
19. Gudnadóttir M., Helgadóttir H., Bjarnason O., Jónsdóttir K. Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol. 1964; 9:85-95.
20. ter Meulen V., Koprowski H., Iwasaki Y., Käckell Y.M., Müller D. Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet. 1972; 2:1-5.
21. Burks J.S., DeVald B.L., Jamkovsky L.D., Gerdes J.C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 1980; 209:933-934
22. Mitchell D.N., Porterfield J.S., Micheletti R., et al. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet. 1978; 2:387-391
23. Melnick J.L., Seidel E., Inoue Y.K., Nishibe Y. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet. 1982; 1:830-833
24. Gajdusek D.C., Gibbs C.J. Jr. Subacute and chronic disease caused by atypical infections with unconventional viruses in aberrant hosts. Perspect Virol. 1973; 8:279-311.
25. Gibbs C.J., Gajdusek D.C., Alpers M.P. Attempts to transmit subacute and chronic neurological diseases to animals. In: Burdzy K, Kallós P, eds. Symposium on pathogenesis and etiology of demyelinating diseases. New York: S Karger, 1969: 519-52.
26. Sibley W.A., Kalter S.S., Laguna J.F. Attempts to transmit multiple sclerosis to newborn and germ-free nonhuman primates: a ten year interim report. In: Bauer HJ, Poser S, Ritter G, eds. Progress in multiple sclerosis research. New York: Springer-Verlag, 1980: 80-8.
27. Adams J.M., Imagawa D.T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962; 111:562-566
28. Norrby E., Link H., Olsson J.-E., Panelius M., Salmi A., Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun. 1974; 10:688-694
29. Kempe C.H., Takabayashi K., Miyamato H., McIntosh K., Tourtellotte W.W., Adams J.M. Elevated cerebrospinal fluid vaccinia antibodies in multiple sclerosis. Arch Neurol. 1973; 28:278-279
30. Thompson J.A., Bray P.F., Glasgow L.A. Multiple sclerosis and elevation of cerebrospinal fluid vaccinia virus antibody. Neurology (Minneap). 1975; 25:94-96
31. Brown P.F., Cathala F., Gajdusek D.C. Further studies of viral antibodies in the cerebrospinal fluid of patients with multiple sclerosis: vaccinia and parainfluenza type 1. Proc Soc Exp Biol Med. 1973; 143:828-829
32. Forghani B., Cremer N.E., Johnson K.B., Ginsberg A.H., Likosky W.H. Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional standards. J Clin Microbiol. 1978; 7:63-69
33. livanainen M.V., Leinikki P.O., Shekarchi I.C., et al. Cerebrospinal fluid antibody pattern in multiple sclerosis by ELISA. Trans Am Neurol Assoc. 1980; 104:125-127
34. Vandvik B., Norrby E. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci USA. 1973; 70:1060-1063
35. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol. 1978; 24:1-39.
36. Mattson D.H., Roos R.P., Arnason B.G.W. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature. 1980; 287:335-337
37. Wylie D.E., Sherman L.A., Klinman N.R. Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J Exp Med. 1982; 155:403-414
38. Greenstein J., McFarland H. Immunologic responses to viruses in multiple sclerosis: cell-mediated immunity. Clin Immunol Allergy, (in press).
39. Brahic M., Haase A.T. Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci USA. 1978; 75:6125-6129
40. Haspel M.V., Lampert P.W., Oldstone M.B.A. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci USA. 1978; 75:4033-4036
41. Knobler R.L., Haspel M.V., Oldstone M.B.A. Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease: I. Genetic control and the murine neuron as the susceptible site of disease. J Exp Med. 1981; 153:832-843
42. Lipton H.H. Theiler#x0027;s virus infection in mice: an unusual byphasic disease process leading to demyelination. Infect Immun. 1975; 11:1147-1155
43. DalCanto M.C., Rabinowitz S.G. Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol. 1982; 11:109-127
44. Paterson P.Y. The demyelinating diseases: clinical and experimental studies in animals and man. In: Samter M, Talmadge DW, Rose B, Austen KF, Vaughan JH, eds. Immunological diseases. 3d ed. Boston: Little, Brown, 1978; 2:1400-1435
45. Rivers T.M., Sprunt D.H., Berry G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med. 1933; 58:39-54.
46. Kies M.W. Immunology of myelin basic proteins. In: Tower DB, ed. The nervous system. New York: Raven Press, 1975; 1:637-646
47. Salk J., Westall F.C., Romine J.S., Wiederholt W.C. Studies on myelin basic protein administration in multiple sclerosis patients. 1. Rationale and preliminary report of immunologic observations. In: Bauer HJ, Poser S, Ritter G, eds. Progress in multiple sclerosis research. Berlin: Springer-Verlag, 1980: 419-27.
48. Raine C.S., Traugott U., Stone S.H. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis. Science. 1978; 201:445-448
49. Brown A., McFarlin D.E., Raine C.S. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest. 1982; 46:171-185
50. Bornstein M.A., Appel S.H. Tissue culture studies of demyelination. Ann NY Acad Sci. 1965; 122:280-286
51. Grundki-Igbal I., Bornstein M.B. Multiple sclerosis: serum gamma globulin and demyelination in organ culture. Neurology (NY). 1980; 30:749-754
52. Panitch H.S., Hooper C.J., Johnson K.P. CSF antibody to myelin basic protein: measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol. 1980; 37:206-209
53. Abramsky O., Lisak R.P., Silberberg D.H., Pleasure D.E., George J. Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med. 1977; 297:1207-1211
54. Tabera T., Webster H.D.F., Wray S.H. Multiple sclerosis cerebrospinal fluid produces myelin lesions in tadpole optic nerves. N Engl J Med. 1976; 295:644-649
55. Traugott U., Snyder S., Raine C.S. Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann Neurol. 1979a; 6:13-20.
56. Tachovsky T.G., Lisak R.P., Koprowski H., Theofilopoulos A.N., Dixon F.J. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet. 1976; 2:997-999
57. Cook S.D., Menonna J., Dowling P.C. Serologic abnormalities in multiple sclerosis. Neurology (Minneap). 1978; 28:129-131
58. Noronha A.B.C., Antel J.P., Roos R.P., Medof M.E. Circulating immune complexes in neurologic disease. Neurology (NY). 1981; 31:1402-7. abstract.
59. Coyle P.K., Brooks B., Hirsch R.L., et al. CSF Fc (IgG) receptor bearing lymphocytes are decreased and immune complexes appear in CSF during multiple sclerosis exacerbations. Neurology (NY). 1980; 20:573. abstract.
60. Paterson P.Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med. 1960; 111:119-136
61. Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol. 1981; 127:1420-1423
62. Lisak R.P., Heinze R.G., Falk G.A., Kies M.W. Search for anti-encephalitogen antibody in human demyelinative diseases. Neurology (Minneap). 1968; 18 (Part 2):122-128
63. Lisak R.P., Zweiman B. In vitro cell-mediated immunity of cerebrospinal fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Engl J Med. 1977; 297:850-853
64. Turk J.L. Delayed hypersensitivity. 3d ed. Vol. 1. Amsterdam: Elsevier Press, 1980.
65. Price R.W., Plum F. Poliomyelitis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology: infections of the nervous system. Part 2. Vol. 34. Amsterdam: Elsevier Press, 1978: 93-132.
66. Engel A.G. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenia syndromes. J Neurol Neurosurg Psychiatry. 1980; 43:577-589
67. Aronson S.M., Bauer H.J., Brown J.R., et al. eds. Therapeutic claims in multiple sclerosis. New York: International Federation of Multiple Sclerosis Societies, 1982: 1-297.
68. Rose A.S., Kuzma J.W., Kurtzke J.F., et al. Cooperative study in the evaluation of therapy in multiple sclerosis — ACTH vs placebo: final report. Neurology (Minneap). 1970; 20(5): Suppl:1-59.
69. Kibler R.F., Paty D.W., Ré P.K., McPhedran A.M., Karp H.R. Effect of large doses of adrenocorticosteroids on the course of EAE and multiple sclerosis. In: Wofgram F, Ellison GW, Stevens JG, Andrews JM, eds. Multiple sclerosis: immunology, virology, and ultrastructure. New York: Academic Press, 1972: 511-39.
70. Brown J.R., Beebe G.W., Kurtzke J.F., Loewenson R.B., Silberberg D.H., Tourtellotte W.W. The design of clinical studies to assess therapeutic efficacy in multiple sclerosis. Neurology (Minneap). 1979; 29:(Suppl) Part 2: 3-23.